|Expense Ratio (net)||1.00%|
|Morningstar Risk Rating||★★|
|Last Cap Gain||0.00|
|Inception Date||Jul 15, 1970|
|Average for Category||N/A|
Our early read on the buying and selling activity of our top managers uncovered a few ideas worth considering.
A New York state judge has dismissed a lawsuit accusing the Sequoia Fund, known for its ties to Warren Buffett, of recklessly making a huge, disastrous investment in Valeant Pharmaceuticals International Inc , causing billions of dollars of losses. Justice O. Peter Sherwood of the State Supreme Court in White Plains, New York, said Sequoia shareholders failed to show it would have been futile, prior to suing in January 2016, to demand that the mutual fund's directors step in to unwind the investment because of their alleged conflicts of interest.
Despite continued poor performance, there's reason for optimism at this Bronze-rated fund.